VCM
BMY icon

Vivaldi Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Vivaldi Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,384
Closed -$206K – 297
2025
Q1 		$206K Buy
+3,384
New +$197K 0.03% 260
2024
Q2 		– Sell
-4,490
Closed -$202K – 231
2024
Q1 		$202K Sell
4,490
-718
-14% -$36.6K 0.06% 211
2023
Q4 		$254K Buy
5,208
+83
+2% +$4.36K 0.08% 182
2023
Q3 		$297K Buy
5,125
+380
+8% +$23.3K 0.1% 146
2023
Q2 		$303K Sell
4,745
-58
-1% -$3.89K 0.09% 144
2023
Q1 		$333K Sell
4,803
-10
-0.2% -$705 0.1% 143
2022
Q4 		$342K Sell
4,813
-59
-1% -$4.45K 0.08% 169
2022
Q3 		$340K Buy
4,872
+42
+0.9% +$3.05K 0.09% 152
2022
Q2 		$372K Buy
4,830
+193
+4% +$14.7K 0.1% 147
2022
Q1 		$351K Sell
4,637
-102
-2% -$6.85K 0.09% 155
2021
Q4 		$295K Buy
4,739
+15
+0.3% +$880 0.07% 165
2021
Q3 		$280K Hold
4,724
– – 0.06% 184
2021
Q2 		$319K Sell
4,724
-240
-5% -$15.6K 0.06% 184
2021
Q1 		$322K Sell
4,964
-1,465
-23% -$91.1K 0.06% 187
2020
Q4 		$399K Buy
6,429
+85
+1% +$5.23K 0.09% 157
2020
Q3 		$404K Sell
6,344
-131
-2% -$7.88K 0.09% 154
2020
Q2 		$412K Buy
6,475
+1,378
+27% +$82.4K 0.09% 153
2020
Q1 		$284K Buy
5,097
+210
+4% +$12.8K 0.06% 156
2019
Q4 		$314K Sell
4,887
-518
-10% -$29.7K 0.08% 165
2019
Q3 		$274K Buy
+5,405
New +$254K 0.06% 175

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vivaldi Capital Management's BMY Position: Q2 2025 in Review

Vivaldi Capital Management sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 3,384 shares — an estimated $206K sold.

Vivaldi Capital Management first reported a position in BMY in Q3 2019 and held it in 20 quarters. The position peaked at $412K in Q2 2020. 2,299 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

  • Vivaldi Capital Management reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
  • Vivaldi Capital Management sold 3,384 Bristol-Myers Squibb shares in Q2 2025, an estimated $206K.
  • Vivaldi Capital Management first reported a position in Bristol-Myers Squibb in Q3 2019 and held it in 20 quarters.
  • Vivaldi Capital Management's Bristol-Myers Squibb position peaked at $412K in Q2 2020.
  • 2,299 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on Vivaldi Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.